
Abigail Louise Vanhorn
Examiner (ID: 11338)
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1616, 1636, 1609 |
| Total Applications | 1393 |
| Issued Applications | 581 |
| Pending Applications | 145 |
| Abandoned Applications | 710 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16761031
[patent_doc_number] => 20210106612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => TARGET GENE TRANSCRIPTIONAL REPRESSION INHIBITOR THAT CAN BE DESIGNED IN A SEQUENCE-SPECIFIC MANNER, COMPOSITION CONTAINING SAME, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/074258
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074258
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074258 | TARGET GENE TRANSCRIPTIONAL REPRESSION INHIBITOR THAT CAN BE DESIGNED IN A SEQUENCE-SPECIFIC MANNER, COMPOSITION CONTAINING SAME, AND USE THEREOF | Jan 31, 2017 | Abandoned |
Array
(
[id] => 11618148
[patent_doc_number] => 20170128335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'KERATIN TREATMENT FORMULATIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/415464
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12603
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415464
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/415464 | Keratin treatment formulations and methods | Jan 24, 2017 | Issued |
Array
(
[id] => 12022195
[patent_doc_number] => 20170312295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'Ophthalmologic Irrigation Solutions and Method'
[patent_app_type] => utility
[patent_app_number] => 15/414930
[patent_app_country] => US
[patent_app_date] => 2017-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12477
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15414930
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/414930 | Ophthalmologic Irrigation Solutions and Method | Jan 24, 2017 | Abandoned |
Array
(
[id] => 12466455
[patent_doc_number] => 09987393
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Covalently cross linked hydrogels and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 15/409392
[patent_app_country] => US
[patent_app_date] => 2017-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3703
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15409392
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/409392 | Covalently cross linked hydrogels and methods of making and using same | Jan 17, 2017 | Issued |
Array
(
[id] => 13024697
[patent_doc_number] => 10034961
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-07-31
[patent_title] => Composite dura substitute implant
[patent_app_type] => utility
[patent_app_number] => 15/405066
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6524
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15405066
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/405066 | Composite dura substitute implant | Jan 11, 2017 | Issued |
Array
(
[id] => 11619680
[patent_doc_number] => 20170129861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => '6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES'
[patent_app_type] => utility
[patent_app_number] => 15/393850
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70972
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15393850
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/393850 | 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides | Dec 28, 2016 | Issued |
Array
(
[id] => 11727462
[patent_doc_number] => 20170188905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'BIOINTERFACE LAYER FOR ANALYTE SENSORS'
[patent_app_type] => utility
[patent_app_number] => 15/394764
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 45547
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15394764
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/394764 | BIOINTERFACE LAYER FOR ANALYTE SENSORS | Dec 28, 2016 | Abandoned |
Array
(
[id] => 11727479
[patent_doc_number] => 20170188922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'BIOINTERFACE LAYER FOR ANALYTE SENSORS'
[patent_app_type] => utility
[patent_app_number] => 15/394706
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 45523
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15394706
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/394706 | BIOINTERFACE LAYER FOR ANALYTE SENSORS | Dec 28, 2016 | Abandoned |
Array
(
[id] => 11554115
[patent_doc_number] => 20170100361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'FUMARATE ESTER DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 15/386133
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 70619
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15386133
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/386133 | Fumarate ester dosage forms | Dec 20, 2016 | Issued |
Array
(
[id] => 12036482
[patent_doc_number] => 09814692
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Fumarate ester dosage forms'
[patent_app_type] => utility
[patent_app_number] => 15/386175
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 72253
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15386175
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/386175 | Fumarate ester dosage forms | Dec 20, 2016 | Issued |
Array
(
[id] => 11689523
[patent_doc_number] => 20170165238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => 'ENHANCED DELIVERY OF IMMUNOSUPPRESSIVE DRUG COMPOSITIONS FOR PULMONARY DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/385369
[patent_app_country] => US
[patent_app_date] => 2016-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14334
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15385369
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/385369 | ENHANCED DELIVERY OF IMMUNOSUPPRESSIVE DRUG COMPOSITIONS FOR PULMONARY DELIVERY | Dec 19, 2016 | Abandoned |
Array
(
[id] => 11961960
[patent_doc_number] => 20170266112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'RESIDENCE STRUCTURES AND RELATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 15/382255
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 75
[patent_no_of_words] => 38920
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382255
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/382255 | RESIDENCE STRUCTURES AND RELATED METHODS | Dec 15, 2016 | Abandoned |
Array
(
[id] => 11528816
[patent_doc_number] => 20170088793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 15/378742
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6837
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15378742
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/378742 | Compounds for a controlled release of active molecules | Dec 13, 2016 | Issued |
Array
(
[id] => 13339985
[patent_doc_number] => 20180221532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => ANTI-ADHESION MATERIAL
[patent_app_type] => utility
[patent_app_number] => 15/504536
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15504536
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/504536 | ANTI-ADHESION MATERIAL | Dec 13, 2016 | Abandoned |
Array
(
[id] => 16837704
[patent_doc_number] => 20210145716
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-05-20
[patent_title] => COMPOSITION FOR HAIR FRIZZ REDUCTION
[patent_app_type] => utility
[patent_app_number] => 15/367356
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15367356
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/367356 | COMPOSITION FOR HAIR FRIZZ REDUCTION | Dec 1, 2016 | Pending |
Array
(
[id] => 16837704
[patent_doc_number] => 20210145716
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-05-20
[patent_title] => COMPOSITION FOR HAIR FRIZZ REDUCTION
[patent_app_type] => utility
[patent_app_number] => 15/367356
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15367356
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/367356 | COMPOSITION FOR HAIR FRIZZ REDUCTION | Dec 1, 2016 | Pending |
Array
(
[id] => 11497930
[patent_doc_number] => 20170072114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'CRYSTALLINE COATING AND RELEASE OF BIOACTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/361426
[patent_app_country] => US
[patent_app_date] => 2016-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 92
[patent_figures_cnt] => 92
[patent_no_of_words] => 35993
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15361426
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/361426 | Crystalline coating and release of bioactive agents | Nov 26, 2016 | Issued |
Array
(
[id] => 12043376
[patent_doc_number] => 09820960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Fumarate ester pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 15/358349
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 51301
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15358349
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/358349 | Fumarate ester pharmaceutical compositions | Nov 21, 2016 | Issued |
Array
(
[id] => 12036480
[patent_doc_number] => 09814691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Fumarate ester pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 15/358305
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28253
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15358305
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/358305 | Fumarate ester pharmaceutical compositions | Nov 21, 2016 | Issued |
Array
(
[id] => 11497795
[patent_doc_number] => 20170071980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'METHOD OF USING OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION IN DENTAL APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/358639
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 29651
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15358639
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/358639 | METHOD OF USING OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION IN DENTAL APPLICATIONS | Nov 21, 2016 | Abandoned |